India to Cambodia: Sofosbuvir Export Trade Route

The India to Cambodia Sofosbuvir corridor is one of India's established pharmaceutical export routes, with 44 shipments documented worth a combined $2.6M USD. The route is dominated by MYLAN LABORATORIES LIMITED, which alone accounts for roughly 91% of all export value, reflecting the consolidated nature of India's sofosbuvir manufacturing sector.

Across 14 active suppliers, the average shipment value stands at $59.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with sofosbuvir's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 26 days port-to-port. The route has recorded an annual growth rate of 30.3%, placing it at rank #17 among India's top sofosbuvir export destinations globally.

On the import side, key buyers of Indian sofosbuvir in Cambodia include NATIONAL CENTER FOR HIV/AIDS,, MINISTRY OF HEALTH CAMBODIA., MINISTRY OF HEALTH CAMBODIA and 20 others. NATIONAL CENTER FOR HIV/AIDS, is the single largest importer with 1 shipments valued at $1.3M USD.

India's sofosbuvir exports to Cambodia are driven primarily by a handful of large-scale manufacturers. MYLAN LABORATORIES LIMITED with 12 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 14 active exporters signals a competitive but concentrated market — buyers in Cambodia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MYLAN LABORATORIES LIMITED, ASPIDA LIFE SCIENCES PRIVATE LIMITED , HETERO LABS LIMITED — together account for 97% of total trade value on this route. The average shipment value of $59.8K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as sofosbuvir 400 mg + daclatasvir 60mg, tab 28 (packs:28's bottle) (13756 packs x 28's=385168 nos) and daclatasvir 60 mg + sofosbuvir + 400mg,tab 28s packs 28s bottle 6500 packs x 28s=182000 nos, suggesting that buyers in Cambodia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, NATIONAL CENTER FOR HIV/AIDS, is the largest importer with 1 shipments worth $1.3M USD — representing 48% of all sofosbuvir imports from India on this route. A total of 23 buyers are active on this corridor.